<html>
<head>PUBMED IDs for KLK11</head>
<body bgcolor='#C5F0F2'><h1>KLK11</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11550212/'>Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines.</a> September 11  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12727843/'>Parallel overexpression of seven kallikrein genes in ovarian cancer.</a> May 3  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12736044/'>Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues.</a> May 9  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12845660/'>Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.</a> July 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12925213/'>Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages.</a> August 20  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15102682/'>Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer.</a> April 23  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16800741/'>mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy.</a> June 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16800740/'>Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.</a> June 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16829021/'>In silico identification and Bayesian phylogenetic analysis of multiple new mammalian kallikrein gene families.</a> July 11  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16911518/'>Multiple promoters regulate tissue-specific alternative splicing of the human kallikrein gene, KLK11/hippostasin.</a> August 17  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17275179/'>Human tissue kallikreins: the cancer biomarker family.</a> February 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17487371/'>Kallikrein 11 expressed in human breast cancer cells releases insulin-like growth factor through degradation of IGFBP-3.</a> May 10  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19190824/'>Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11.</a> March 21  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19242826/'>Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer.</a> June 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20302517/'>Interdependence of kallikrein-related peptidases in proteolytic networks.</a> August 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20302451/'>Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).</a> June 10  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20940292/'>Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.</a> February 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21628462/'>Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors.</a> September 17  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22429520/'>Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer.</a> September 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23647300/'>Identification of HOXB8 and KLK11 expression levels as potential biomarkers to predict the effects of FOLFOX4 chemotherapy.</a> November 2  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24553122/'>Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.</a> May 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24854539/'>Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma.</a> June 3  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25123036/'>KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients.</a> August 25  2014<br></body></html>
